XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.78−0.07 (-3.78%)
Close on Nov 17, 2026Market cap $54.27MP/E –Yield –
XBiotech revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
XBiotech's revenue for the twelve months ending Dec 31, 2023 was $0, down 100.0% year over year. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $44.00M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $4.01M | -78.2% |
| FY2021 | Dec 31, 2021 | $18.39M | -58.2% |
| FY2020 | Dec 31, 2020 | $44.00M | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2018 | Dec 31, 2018 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $0 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | $300.00K | -93.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.68M | -62.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.53M | -66.2% |
| Q1 FY2022 | Mar 31, 2022 | $500.00K | -89.7% |
| Q4 FY2021 | Dec 31, 2021 | $4.50M | -14.6% |
| Q3 FY2021 | Sep 30, 2021 | $4.52M | -57.2% |
| Q2 FY2021 | Jun 30, 2021 | $4.53M | -70.8% |
| Q1 FY2021 | Mar 31, 2021 | $4.85M | -61.8% |
| Q4 FY2020 | Dec 31, 2020 | $5.27M | – |
| Q3 FY2020 | Sep 30, 2020 | $10.55M | – |
| Q2 FY2020 | Jun 30, 2020 | $15.50M | – |
| Q1 FY2020 | Mar 31, 2020 | $12.68M | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $0 | – |
See a number that looks wrong?